Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;59(7):1686-93.
doi: 10.2337/db09-0630. Epub 2010 Apr 22.

Inhibition of beta-cell sodium-calcium exchange enhances glucose-dependent elevations in cytoplasmic calcium and insulin secretion

Affiliations

Inhibition of beta-cell sodium-calcium exchange enhances glucose-dependent elevations in cytoplasmic calcium and insulin secretion

Kevin S C Hamming et al. Diabetes. 2010 Jul.

Abstract

Objective: The sodium-calcium exchanger isoform 1 (NCX1) regulates cytoplasmic calcium (Ca(2+)(c)) required for insulin secretion in beta-cells. NCX1 is alternatively spliced, resulting in the expression of splice variants in different tissues such as NCX1.3 and -1.7 in beta-cells. As pharmacological inhibitors of NCX1 splice variants are in development, the pharmacological profile of beta-cell NCX1.3 and -1.7 and the cellular effects of NCX1 inhibition were investigated.

Research design and methods: The patch-clamp technique was used to examine the pharmacological profile of the NCX1 inhibitor KB-R7943 on recombinant NCX1.3 and -1.7 activity. Ca(2+) imaging and membrane capacitance were used to assess the effects of KB-R7943 on Ca(2+)(c) and insulin secretion in mouse and human beta-cells and islets.

Results: NCX1.3 and -1.7 calcium extrusion (forward-mode) activity was approximately 16-fold more sensitive to KB-R7943 inhibition compared with cardiac NCX1.1 (IC(50s) = 2.9 and 2.4 vs. 43.0 micromol/l, respectively). In single mouse/human beta-cells, 1 micromol/l KB-R7943 increased insulin granule exocytosis but was without effect on alpha-cell glucagon granule exocytosis. KB-R7943 also augmented sulfonylurea and glucose-stimulated Ca(2+)(c) levels and insulin secretion in mouse and human islets, although KB-R7943 was without effect under nonstimulated conditions.

Conclusions: Islet NCX1 splice variants display a markedly greater sensitivity to pharmacological inhibition than the cardiac NCX1.1 splice variant. NCX1 inhibition resulted in glucose-dependent increases in Ca(2+)(c) and insulin secretion in mouse and human islets. Thus, we identify beta-cell NCX1 splice variants as _targets for the development of novel glucose-sensitive insulinotropic drugs for type 2 diabetes.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
KB-R7943 inhibits FM NCX1 activity in a splice variant–dependent manner. A: Representative current recordings of NCX1.1, -1.3, and -1.7 splice variants demonstrating that the β-cell NCX1 splice variants, NCX1.3 and -1.7, display FM inactivation, whereas the cardiac NCX1.1 splice variant does not. B–D: Representative current recordings illustrating that FM NCX1.1 activity is resistant to inhibition by 5 μmol/l KB-R7943, whereas NCX1.3 and -1.7 displayed marked KB-R7943 inhibition. E: KB-R7943 concentration-inhibition curves for NCX1.1, -1.3, and -1.7 FM currents. F: Diagrammatic representation of the alternative splicing region exon composition for various NCX1 splice variants. G: Grouped KB-R7943 (5 μmol/l) inhibition data for FM NCX1.1, -1.11, -1.3, -1.4, and -1.7 currents. *P < 0.05, n = 7–10 patches per group. 0 = <1 μmol/l Ca2+. NCX1 proteins were expressed in tsA201 cells.
FIG. 2.
FIG. 2.
The late FM NCX1.3 and -1.7 currents are more sensitive to KB-R7943 inhibition (3 μmol/l) compared with peak currents. Representative recordings of NCX1.3 (A) and -1.7 (C) FM currents before (control) and after the application of 3 μmol/l KB-R7943. Concentration-response curves for NCX1.3 (B) and -1.7 (D) late and peak KB-R7943 FM current inhibition demonstrating that KB-R7943 preferentially inhibits the late FM currents compared with peak FM currents. *P < 0.05, n = 4–10 patches per concentration. 0 = <1 μmol/l Ca2+. NCX1 proteins were expressed in tsA201 cells.
FIG. 3.
FIG. 3.
Calcium imaging of mouse islets. A: Application of 20 μmol/l tolbutamide (Tolb) to islets superfused with 2.8 mmol/l glucose increases Ca2+c levels that are lower upon a second tolbutamide application. B: In contrast, the addition of 1 μmol/l KB-R7943 significantly increases the magnitude of Ca2+c elevation observed during the second application of tolbutamide. KB-R7943 does not increase Ca2+c levels when applied alone in the presence of 2.8 mmol/l glucose. Ci: Grouped data showing that KB-R7943 significantly increases Ca2+c levels (*P < 0.05, n = 6–11 islets) in the presence of tolbutamide or KCl. Cii: Grouped data showing that in the absence of the tolbutamide or KCl stimulatory signal, KB-R7943 does not increase Ca2+c (n = 6–9 islets). D: Grouped data indicating that the rate at which Ca2+c returned to basal levels is slower in the presence of KB-R7943 for both tolbutamide and KCl (*P < 0.05, n = 6–9 islets). E: Increasing glucose from 2.8 to 11.1 mmol/l elicited increases in Ca2+c, whereas 1 μmol/l KB-R7943 did not increase Ca2+c at 2.8 mmol/l glucose but significantly increased Ca2+c in 11.1 mmol/l glucose when compared with 11.1 mmol/l glucose alone. Grouped data showing that 1 μmol/l KB-R7943 significantly increased the peak (Δpeak) (Fi) and average Ca2+c (AUC) in response to 11.1 mmol/l glucose (Fii). *P < 0.05, n = 9 islets per group.
FIG. 4.
FIG. 4.
NCX1 inhibition and Ca2+-dependent exocytosis in β- and α-cells. Representative capacitance measurements and grouped data of cumulative changes at individual pulse numbers from mouse and human β-cells with reduced NCX1 expression (Ad-shNCX1), scrambled control vector (Ad-scramble) (A), or in the presence of 1μmol/l KB-R7943 (C and E) in response to a depolarizing train of membrane potential pulses. B: Western blot analysis (i, ii) showing that NCX1 protein expression is only partially reduced as a result of Ad-shNCX1 infection in MIN6 cells (i–iii). β-actin (i) and total ACC (ii) were used as loading controls. D: Representative capacitance measurements and grouped data for calcium infusion experiments in the presence and absence of 1μmol/l KB-R7943. F: Representative capacitance measurements and grouped data from mouse α-cells in response to 1 μmol/l KB-R7943. *P < 0.05, n = 8–20 cells per group or three separate lysates (B).
FIG. 5.
FIG. 5.
Glucose-stimulated insulin secretion from mouse and human islets in response to elevations in glucose from 2.8 to 11.1 mmol/l (denoted by arrows). KB-R7943 (1 μmol/l) augments insulin secretion from mouse (A) and human (B) islets only in the presence of elevated glucose (11.1 mmol/l). *P < 0.05, n = 5–6 for mouse and 2–3 for humans.

Similar articles

Cited by

References

    1. Festa A, Williams K, Hanley AJ, Haffner SM: β-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test. Diabetes 2008;57:1638–1644 - PubMed
    1. UK Prospective Diabetes Study Group U.K. Prospective Diabetes Study 16: overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 1995;44:1249–1258 - PubMed
    1. Del Prato S, Aragona M, Coppelli A: Sulfonylureas and hypoglycaemia. Diabetes Nutr Metab 2002;15:444–450; discussion 450–441 - PubMed
    1. Amiel SA, Dixon T, Mann R, Jameson K: Hypoglycaemia in type 2 diabetes. Diabet Med 2008;25:245–254 - PMC - PubMed
    1. Rorsman P, Renstrom E: Insulin granule dynamics in pancreatic beta cells. Diabetologia 2003;46:1029–1045 - PubMed

Publication types

MeSH terms

  NODES
Note 1
twitter 2